FDA Seeks Injunction Against ‘Anticancer’ Drug Maker
ROCKVILLE, Md-The FDA has accused Lane Labs-USA, Inc., of Allendale, NJ, with illegally promoting three products as treatments for cancer and other diseases, and is seeking a permanent federal court injunction against the marketing of the products: BeneFin, produced from shark cartilage; SkinAnswer, a glycoalkaloid skin cream; and MGN-3, a rice-bran extract.
ROCKVILLE, MdThe FDA has accused Lane Labs-USA, Inc., of Allendale, NJ, with illegally promoting three products as treatments for cancer and other diseases, and is seeking a permanent federal court injunction against the marketing of the products: BeneFin, produced from shark cartilage; SkinAnswer, a glycoalkaloid skin cream; and MGN-3, a rice-bran extract.
The FDA noted that BeneFin is being studied as a cancer therapy under an investigational new drug application and it can be distributed for clinical trials. The legal action does not affect shark cartilage products that are lawfully marketed as dietary supplements.
![We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fd5a069c33bbfe917bc7c0b1bb13d76c0a815cc44-234x234.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.")
